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Abstract
The activation of G-protein coupled receptors by agonist compounds results in diverse bio-
logical responses in cells, such as the endocytosis process consisting in the translocation
of receptors from the plasma membrane to the cytoplasm within internalizing vesicles or en-
dosomes. In order to functionally evaluate endocytosis events resulted from pharmacologi-
cal responses, we have developed an image analysis method –the Q-Endosomes
algorithm– that specifically discriminates the fluorescent signal originated at endosomes
from that one observed at the plasma membrane in images obtained from living cells by
fluorescence microscopy. Mu opioid (MOP) receptor tagged at the carboxy-terminus with
yellow fluorescent protein (YFP) and permanently expressed in HEK293 cells was used as
experimental model to validate this methodology. Time-course experiments performed with
several agonists resulted in different sigmoid curves depending on the drug used to initiate
MOP receptor endocytosis. Thus, endocytosis resulting from the simultaneous activation of
co-expressed MOP and serotonin 5-HT2C receptors by morphine plus serotonin was signifi-
cantly different, in kinetics as well as in maximal response parameters, from the one caused
by DAMGO, sufentanyl or methadone. Therefore, this analytical tool permits the pharmaco-
logical characterization of receptor endocytosis in living cells with functional and temporal
resolution.
Introduction
Endocytosis of G-protein coupled receptors (GPCRs) is a cellular event that generally occurs
upon receptor activation by agonist compounds. Essentially, the process consists in the forma-
tion and inward cytosolic movement of vesicles originated at the plasma membrane. As a conse-
quence, activated receptors abandon the cell surface within these vesicles, termed endosomes, to
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follow different sorting pathways leading them to degradation or recycling back to the plasma
membrane [1]. In fact, endocytosis has been traditionally considered as a mechanism to inter-
rupt the different intracellular signaling cascades initiated by receptor activation, although that
widely accepted paradigm has been brought into question after a recent report demonstrating
β2 adrenoceptor intracellular signaling activity from endosomes [2].
Fluorescence microscopy technology has made feasible to observe receptor endocytosis at
subcellular resolution. Moreover, the development of recombinant DNA technologies has per-
mitted to tag receptors with fluorescent proteins in order to make them visible by fluorescence
microscopy after their heterologous expression in cell lines. In this model, both receptor and
fluorescent protein constitute a single fusion protein possible to be observed throughout the
different cellular compartments without the participation of additional labelling elements such
as antibodies or fluorescent ligands [3]. One of the main advantages of this methodology is the
possibility of carrying out imaging experiments with living cells and to observe, for instance,
with high spatial and temporal resolution the formation of endocytic vesicles and their subse-
quent internalisation from the plasma membrane to the cytoplasm in real time. By using this
experimental approach, we previously described that coactivation of serotonin 5-HT2A recep-
tor facilitates morphine internalization of the mu opioid receptor (MOP) expressed in a heter-
ologous/inducible cell system [4].
The faculty of an agonist to promote a response through a given receptor in a specific tissue
is known as efficacy. This attribute is inherent to the chemical nature of the compound, relative
when comparing agonist drugs to each others and, interestingly, it depends on the type of re-
sponse considered for evaluation, i.e., some agonists presenting a significant efficacy for a par-
ticular response may be incompetent to evoke a reaction to a different functional effect. This
later property, which is known in pharmacology as biased agonism or functional selectivity, is
defined as the ability of different agonists for a particular receptor to differentially activate ei-
ther signalling cascades or regulatory events, including differences in receptor trafficking [5].
Mu opioid (MOP) receptor constitutes a patent example of functional selectivity in relation to
the capacity of some agonists to promote endocytosis upon receptor activation [6]; thus, while
agonists such as DAMGO (Tyr-D-Ala-Gly-N-Met-Phe-Gly-ol) and morphine display intrinsic
activity in both G-protein coupling ([35S]GTPγS binding) and adenylyl cyclase inhibition as-
says, they are completely disparate in terms of generating receptor internalization since mor-
phine is incapable to induce MOP receptor endocytosis in the majority of cellular systems
[7–9]. There are numerous experimental data supporting the hypothesis that associates the in-
efficiency of morphine to induce endocytosis of MOP receptors at the cellular level with the
high degree of tolerance to antinociceptive effects developed after morphine sustained treat-
ment (for a review on this topic see [8–10]). According to this, investigations on experimental
conditions facilitating the internalization of MOP receptors by morphine would be an objective
in the direction to model new therapeutic strategies for treatment of chronic pain.
Receptor pharmacology is a quantitative discipline, and therefore any biological effects gen-
erated as a result of ligand-receptor interactions should be monitored by analytical means pro-
viding measurable magnitudes corresponding to pharmacological properties of those
compounds, i.e., affinity to bind to a specific site and/or potency and efficacy to evoke a biologi-
cal response. In this respect, however, there is a deficiency of quantitative methods to accurate-
ly evaluate the functionality of GPCRs in terms of agonist efficacy to promote endocytosis. For
this reason, we have created an algorithm that detects and measures endosomes by analysing
images obtained from living cells by epifluorescence microscopy in real time. We opted for
MOP receptor fused to YFP at the carboxyl terminus and permanently expressed in HEK 293
cells as a experimental model for validating our methodology because the following reasons:
firstly, in basal conditions MOP receptors are predominantly located at the plasma membrane
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in these host cells and secondly, the existence of agonist drugs for this receptor clearly differen-
tiated among them in terms of their capacity to induce MOP receptor internalization. In addi-
tion, the versatility of this experimental approach has been tested with another GPCR, i.e. delta




All materials for tissue culture were from Life Technologies. Doxycycline, serotonin (5-HT),
DTLET and DAMGO, were from Sigma-Aldrich. (±)DOI andWAY161503 were supplied by
Tocrys Bioscience. Morphine and methadone was obtained from Alcaliber and sufentanyl was
generously gifted by Prof. María del Amor Hurlé from the Department of Pharmacology and
Physiology (University of Cantabria).
Receptor Fusions with Fluorescent Proteins
Generation and subcloning of the human 5-HT2C receptor construct was essentially as de-
scribed previously (4). Briefly, the c-myc epitope tag was added at the amino terminus of the
receptor by PCR techniques using forward primers containing the sequence of the c-myc epi-
tope (amino acid sequence EQKLISEEDL). A c-myc-5-HT2C receptor C-terminally tagged
with a version of the enhanced cyan fluorescent protein (eCFP) called Cerulean was con-
structed by amplifying the sequence corresponding to the receptor by PCR and by removing
the stop codon. This PCR product was ligated to the fluorescent protein sequence amplified by
PCR and containing the same endonuclease restriction site (NotI). The final product of this li-
gation corresponds to a single open reading frame encoding the receptor-fluorescent protein
fusion. c-myc-5-HT2C-Cerulean was subcloned into the vector pcDNA5/FRT/TO (Life Tech-
nologies) for the subsequent generation of Flp-In T-REx HEK293 cell lines. MOP-YFP receptor
was obtained after amplification of human MOP using PCR primers containing a SacI endonu-
clease site at the 50 end and an ApaI endonuclease site at the 30 end and in the process removing
the stop codon. This PCR product was subcloned into peYFP-N1 vector, resulting in a single
open reading frame consisting of the MOP receptor with eYFP (enhanced Yellow Fluorescent
Protein) fused to the receptor carboxyl terminus. DOP-YFP receptor construct was engineered
following a similar experimental strategy. All the constructs were verified by DNA sequencing.
Generation of Stable Flp-In T-REx HEK293 Cell Lines
To generate Flp-In T-REx HEK293 cell lines able to express c-myc-5-HT2C-Cerulean in an in-
ducible manner, cells were transfected with a mixture containing the c-myc-5-HT2A-Cerulean
receptor cDNA in the pcDNA5/FRT/TO vector and pOG44 vector (1:9) using the polyethyle-
nimine method described elsewhere [24]. When cotransfected with the pcDNA5/FRT plasmid
into the Flp-In mammalian host cell line, the Flp recombinase expressed from pOG44 mediates
integration of the pcDNA5/FRT vector containing the gene of interest into the genome via Flp
recombination target (FRT) sites. Cell maintenance and selection were as described [25].
Clones resistant to hygromycin were screened for c-myc-5-HT2C-Cerulean expression by both
fluorescence andWestern blotting. To induce expression of c-myc-5-HT2C-Cerulean cells were
treated with varying concentrations of doxycycline for different periods. The optimal expres-
sion of c-myc-5-HT2C-Cerulean was achieved after 24-h treatment with 0.01 μg of doxycy-
cline/ml growth medium. A double stable cell line expressing MOP-eYFP constitutively and c-
myc-5-HT2C-Cerulean in an inducible manner was generated from the Flp-In T-REx HEK293
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cells described above. Cells were transfected using the polyethylenimine method with the vec-
tor containing MOP-eYFP. Following transfection, cells were selected for resistance to Geneti-
cin (G418; 1 mg/ml; InvivoGen), and the resistant clones were screened for receptor expression
by fluorescence microscopy. Dialyzed fetal calf serum was used for cell growth to avoid activa-
tion of c-myc-5-HT2C-Cerulean by 5-HT that is present routinely in serum.
Cell Transient Transfection
Flp-In T-REx HEK293 and HeLa cells were maintained in Dulbecco’s modified Eagle’s medi-
um supplemented with 0.292 g/l L-glutamine and 10% (v/v) newborn calf serum at 37°C in a
5% CO2 humidified atmosphere. Cells were grown to 60–80% confluence before transient
transfection. Transfection was performed by the polyethylenimine method (24).
Living Cell Confocal Microscopy
Cells expressing receptors tagged with Cerulean or eYFP were grown on poly-d-lysine-treated
coverslips. The coverslips were placed into a microscope chamber containing physiological sa-
line solution (130 mMNaCl, 5 mM KCl, 1 mM CaCl2, 1 mMMgCl2, 20 mMHEPES, and
10 mM d-glucose, pH 7.4). Confocal images (512x512 pixels; 0.15m pixel size) were acquired at
room temperature in a SP-5 laser-scan confocal microscope (Leica Microsystems) with a 40x
1.25NA oil objective, a 1 Airy pinhole, a 5x electronic zoom and 200Hz speed. Cells were excit-
ed sequentially with 548nm and 514nm laser lines and emission captured between 465-511nm
(CFP) and 525-575nm (YFP). Images are presented after digital adjustment of brightness and
contrast to maximize signal.
Living Cell Epifluorescence Microscopy
Flp-In T-REx HEK293 permanently expressing MOP-YFP receptors and treated for 24 hours
with doxycycline [0.01 μg/ml] to induce the expression of c-myc-5-HT2C-Cerulean receptors
were grown on poly-d-lysine-treated coverslips. The coverslips were placed into a microscope
chamber containing physiological saline solution (130 mMNaCl, 5 mM KCl, 1 mM CaCl2, 1
mMMgCl2, 20 mMHEPES, and 10 mM d-glucose, pH 7.4). For internalization experiments in
real time, drugs diluted in physiological saline solution were perfused into the microscope
chamber and7 m thick Z-stacks (15 planes of 0.49 m Z-step size) were acquired for 15 min-
utes at a rate of 1 frame per minute in an inverted epifluorescence microscope (AF6500; Leica
Microsystems) equipped with temperature control (PeCon GmbH) at 37ºC. Cell fluorescence
were visualized with a 63x 1.3NA oil objective, 470/40 excitation and 515LP emission filters,
and images (1004x1002 pixels; 0.13m pixel size) were acquired with a DU8285_VP (Andor
Technology) camera using exposures of 200ms or less and an EM Gain of 20.
Algorithm for Detecting and Quantifying Endosomes
In order to quantify endosomes we have designed the Q-Endosomes algorithm in Matlab that
selectively identifies high intensity local maxima with the typical shape of an endosome (S1
Q_Endosomes). Fluorescence signal from endosomes is characterized by a 2D-Gaussian shape
of a given width indicated by the parameter sigma (σ). A 2D-Gaussian function of unity ampli-
tude, with the same sigma value in both x and y axis, and centered at 0, can be expressed as:
g x; yð Þ ¼ ex
2þy2
2s2
The algorithm consists of the following steps that are iteratively repeated for the data ac-
quired at each time point. Firstly, each z-plane image (1004x1002 pixels) is ﬁltered with a
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2D-Gaussian of sigma 1 pixel (0.13 μm). This step aims to reduce instrumental noise resulting
in smoother images. Secondly, to obtain a 2D projection of the 3D data, the maximum value
across z-planes is selected for each pixel, i.e. z-projection. Thirdly, the algorithm identiﬁes all
local maxima that are a given percent above the local background (by default 90%). Hence,
only local maxima with a relatively high intensity are selected as candidates. Finally, a 9x9 pixel
region centered at each candidate is ﬁtted to a 2D-Gaussian function of sigma 2.30 pixels
(0.29 μm), corresponding to the width of an average real endosome. The value of this later pa-
rameter was experimentally determined, and it is critical to distinguish the ﬂuorescence emit-
ted by endosomes from the plasma membrane ﬂuorescence since the distinctive sigma of the
membrane is signiﬁcantly higher (i.e. 5.15 pixels, see S1C Fig). A candidate local maxima is
thus considered a real endosome if the correlation with the abovementioned 2D-Gaussian
function is higher than 0.75 (see S2 Fig, S1 Supplemental Data for algorithm details and Matlab
code in S1 Q_Endosomes).
The accuracy of the algorithm was assessed by using a model where a known number of simu-
lated endosomes were randomly placed. These endosomes had the same features, in terms of
sigma and intensity distribution, than a sample of manually identified endosomes (N = 150,
sigma = 2.07 ± 0.53 pixels before smoothing, intensity = 1652 ± 178 arbitrary fluorescence units;
mean ± SD). Accuracy, defined as the proportion of endosomes correctly detected, was higher
than 90% for a model comprising between 0 and 800 simulated endosomes. (See S1 Supplemental
Data).
Quantitative Analysis of Endocytosis by Sigmoid Function Fitting
The kinetics of the number of endosomes generated upon agonist stimulation was analyzed
using Prism (GraphPad Software Inc.). Quantification of endocytosis in terms of number of en-
dosomes as a function of time was fitted to a sigmoid function according to the following equa-
tion:
y ¼ bottomþ top bottomð Þ
1þ 10 time1=2Xð Þslope½ 
When comparing parameters from different experimental conditions statistical signiﬁcance
was determined using an ANOVA followed by the post hoc analysis as appropriate. P< 0.05
determined statistical signiﬁcance.
Results and Discussion
Similarly as described earlier [4], we generated a double stable Flp-In HEK293 cell line perma-
nently expressing MOP-YFP receptors and harbouring serotonin c-myc-5-HT2C-Cerulean re-
ceptors in the inducible locus. Images obtained from these cells by confocal microscopy show a
homogenous distribution of MOP-YFP receptors essentially confined to the plasma membrane
when samples were illuminated to excite YFP light emission (Fig 1). Equivalent microscopic
fields illuminated to visualize CFP (Cerulean) resulted in a complete absence of specific fluores-
cent signal (Fig 1). On the other hand, specific CFP signal corresponding to Cerulean protein
was detected when cells were pre-treated with doxycycline for 24 hours to induce the expres-
sion of c-myc-5-HT2C-Cerulean receptors (Fig 1). The cellular distribution of MOP receptors
was not affected by doxycycline treatment, and although c-myc-5-HT2C-Cerulean receptors
are also expressed in intracellular compartments, both opioid and serotonin receptors seem to
colocalize at the plasma membrane level (Fig 1).
Treatment of cells only expressing opioid receptors with the synthetic enkephalin analogue
DAMGO for 30 minutes resulted in a redistribution of the YFP fluorescent signal to cytosolic
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compartments in the form of dots and punctuate aggregates (Fig 2), suggesting the occurrence of
endocytosis upon this agonist treatment. On the contrary, MOP-YFP receptors hardly internal-
ize when equivalent experiments were conducted with morphine (Fig 2). We recently described
that MOP receptor internalization by morphine is facilitated by a mechanism depending on
Gαq/11 coupling and PKC activation when serotonin 5-HT2A receptors expressed in the same
cells were concomitantly activated [4]. Serotonin 5-HT2C receptor exhibits a high structural ho-
mology to 5-HT2A and as a result both receptors initiate basically the same cell signalling cas-
cades upon activation [11]; consequently, it could be anticipated a potentiation of MOP receptor
endocytosis promoted by morphine when 5-HT2C receptor is concomitantly stimulated. Indeed,
when c-myc-5-HT2C-Cerulean receptors were induced to express in the double-stable cell line,
treatment of cells with morphine in combination with serotonin for 30 minutes resulted in the
internalization of the opioid receptor at an apparent similar extent to that observed for equiva-
lent assays performed with DAMGO (Fig 2). Conversely, either morphine or serotonin failed to
evoke MOP-YFP receptor endocytosis when used separately (Fig 2).
Time-lapse images obtained by epifluorescence microscopy from cells expressing both re-
ceptors and treated for 15 minutes with DAMGO, sufentanyl, morphine plus serotonin or
Fig 1. Generation of an inducible double-stable cell line expressing MOP-YFP and c-myc-5-HT2C-
Cerulean receptors. Images obtained by confocal microscopy from living Flp-In HEK293 cells expressing
permanently MOP-YFP receptors and c-myc-5-HT2C-Cerulean receptors in an inducible manner. The right
column corresponds to the images resulting after exciting the cells with the YFP light settings whereas in the
left column are the samemicroscopy field illuminated for CFP visualization. When indicated, +DOX
corresponds to treatment with doxycycline (0.01 μg/ml) for 24 hours prior to microscope observation.
doi:10.1371/journal.pone.0122604.g001
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morphine all of them at maximal efficacious doses (S1 Video) confirmed the incapability of
morphine to induce MOP-YFP receptor internalization. Additionally, detailed observations of
these movies revealed that the endocytosis promoted by morphine plus serotonin was clearly
differentiated from those ones resulted for DAMGO and sufentanyl in both temporal and
quantitative terms. This observation prompted us to conceive an analytical method (i.e. the
Q-Endosomes algorithm) to evaluate the appearance of endosomes as a result of receptor acti-
vation by agonists in images obtained from real time experiments. Based in diverse analytical
approaches previously described to detect endosomes in images obtained by fluorescence mi-
croscopy, particularly those ones used for single particle tracking (SPT) studies [12–14], we
have developed a computer algorithm that identifies multiple particles corresponding to endo-
somes while discriminates these punctuate particles from the fluorescent signal corresponding
to the cell plasma membrane. At difference of more comprehensive SPT methods, our interest
at this point is focussed in the identification and discernment of endosomes as long as they be-
come visible at the different time points upon receptor agonist stimulation rather than being
concerned in the dynamics of endocytic vesicles through intracellular compartments once they
were formed. Therefore and taking into account this premise, the Q-Endosomes algorithm was
devised to detect fluorescent objects that fulfilled the following criteria: firstly, the particle was
a local maxima; secondly, its intensity value was higher than the local background, and thirdly,
it fitted adequately (R>0.75) a 2D-Gaussian function with a sigma value equivalent to 2.30 pix-
els (corresponding to 0.29 μm; see S1 Supplemental Data for a more detailed description of the
algorithm development). To graphically illustrate the process, Fig 3 shows a particular micros-
copy field before (column 1, time = 0 minutes) and after (column 2, time = 10 minutes) treat-
ment with DAMGO (10μM). Detailed images of an individual cell (Fig 3B) display those local
maxima initially detected by the algorithm (red circles) and which of them are selected as
Fig 2. MOP-YFP receptor endocytosis studies in living cells by confocal microscopy. Upper panels:Confocal microscopy images from Flp-In HEK293
cells permanently expressing MOP-YFP receptors without induction of c-myc-5-HT2C-Cerulean receptor expression. Cells were treated with either DAMGO
(10 μM) (left panel) or morphine (10 μM) (right panel) for 30 minutes before picture acquisition. Lower panels: Images from cells treated with doxycycline
(0.01 μg/ml) for 24 hours in order to express c-myc-5-HT2C-Cerulean receptors. Cells were treated with either DAMGO (10 μM), morphine (10 μM), 5-HT
(10 μM) or morphine plus 5-HT for 30 minutes before picture acquisition.
doi:10.1371/journal.pone.0122604.g002
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endosomes (green circles). Basically, by introducing the Gaussian fitting, this image analysis
method is able to differentiate the fluorescent signal following a crest contour as observed in
the plasma membrane (Fig 3, C1), from that one closest to a spiky pattern of distribution
Fig 3. Selective detection of endosomes in fluorescence microscopy images from living cells. A1,2:
Images corresponding to the samemicroscope field acquired at time = 0 (A1) and at time = 10 (A2) minutes
upon DAMGO (10 μM) treatment.B1,2:Detailed images from cells indicated by the white frame in panels A.
Green circles correspond to those local maxima (red circles) identified as endosomes by the algorithm.C1,2:
3D representation of the intensity of fluorescence signal from cells shown in panels B. Fluorescence
corresponding to the plasmamembrane follows a crest silhouette (C1) whereas endosome signal distribute
as a spiky pattern (C2).
doi:10.1371/journal.pone.0122604.g003
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typical of endosomes (Fig 3, C2). In order to evaluate the accuracy of the method, which we es-
timated to be above 90% (see S1 Supplemental Data), we tested the algorithm on simulated
data by adding a known number of randomly distributed endosomes to a baseline image.
Graphical representations of the number of fluorescent spots generated at different time
points by activation of MOP-YFP receptors with several opioid agonists resulted in a data dis-
tribution fitting to a sigmoidal function, as shown by representative results in Fig 4.
By this new approach, the kinetics of this process can be precisely described in terms of the
three characteristic parameters of a sigmoid curve, i.e., the maximal effect (Emax) in this case
the maximum number of spots detected corresponding to internalizing vesicles or endosomes
per cell, the time to reach the 50% of that maximal response defined as half time (t1/2) and the
steepness of the curve (slope). Tables 1 and 2 summarize the values corresponding to these pa-
rameters from independent experiments performed in cells expressing MOP-YFP receptors
alone and cells expressing c-myc-5-HT2C-Cerulean and MOP-YFP receptors simultaneously.
Cells only expressing MOP-YFP receptors showed a robust receptor internalization when they
were treated for 15 minutes with DAMGO (10 μM), sufentanyl (1μM) and methadone (10 μM)
with no significant difference among them in relation to t1/2, maximum number of vesicles per
cell or curve slope (one-way ANOVA, P>0.05). In all the three cases the maximal effect (be-
tween 20 and 27 vesicles per cell) was reached in about 10 minutes with a half time of 5 minutes
approximately (Table 1). Conversely, neither morphine, oxycodone nor buprenorphine gener-
ated significant endocytosis of MOP-YFP receptors upon 15 minutes of treatment at 10 μM.
Equivalent experiments were conducted in cells pre-treated with doxycycline to induce the ex-
pression of c-myc-5-HT2C-Cerulean receptors (Table 2). In this later case, either kinetics pa-
rameters (t1/2 and curve slope) as maximum response (Emax) observed for DAMGO,
sufentanyl, methadone and morphine were not significantly different to the ones obtained with
the same compounds in cells only expressing MOP-YFP receptors (t-test, P>0.05). As we men-
tioned above when describing the characterisation of the double-stable cell line by confocal mi-
croscopy, the co-activation of c-myc-5-HT2C-Cerulean with serotonin (5-HT) facilitates the
endocytosis of MOP-YFP receptors by morphine at an apparent extent than DAMGO. Howev-
er, the quantitative analysis of equivalent experiments conducted in real time by epifluores-
cence microscopy with living cells revealed that both processes, i.e., MOP-YFP endocytosis
induced by either DAMGO or morphine plus 5-HT, were significantly different in terms of ki-
netics (t1/2) and efficacy (Emax) (one-way ANOVA P<0.005) (Fig 4 and Table 2). That capaci-
ty to distinguish among different endocytosis events depending on the agonist compounds
used to initiate the process demonstrates the selectivity of this new method. In a similar way,
experiments using other agonists for 5-HT2C receptors known to be partially efficacious in rela-
tion to 5-HT in more conventional functional assays were conducted to confirm the robustness
of this technique. Thus, treatment of cells with either DOI (10 μM) or WAY161503 (1μM) in
conjunction with morphine resulted in MOP-YFP receptor endocytosis kinetically equivalent
to the one observed when 5-HT was used as agonist (Table 2); on the contrary, both DOI and
WAY161503 generated a significant lower number of vesicles per cell than 5-HT (t-test
P<0.05) (Table 2). Therefore, these results indicate that the differences in intrinsic activity
among 5-HT, DOI and WAY161503 observed previously in both intracellular calcium mobili-
sation assays and endocytosis induction of 5-HT2C-GFP receptors transiently expressed in
HEK293 cells [15] are also discernible with this approach when evaluating the effect of these
agonists to facilitate MOP-YFP endocytosis by morphine. Intriguingly, that facilitation of
MOP-YFP internalization observed in the case of morphine was not emulated by other opioid
agonist such as oxycodone or buprenorphine also incompetent by themselves to promote
MOP receptor endocytosis.
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Fig 4. Time course of the generation of endocytic vesicles containing MOP-YFP receptors upon
treatment with different agonist compounds. A.Graph shows the quantitative data obtained after image
analysis of cells expressing MOP-YFP receptors and treated with DAMGO (10 μM) (black circles), sufentanyl
(1 μM) (red circles) or morphine (10 μM) (open circles) for 15 minutes. Each point represents the mean ± SEM
of at least three independent assays.B. Data corresponding to equivalent experiments from cells co-
expressing MOP-YFP and c-myc-5-HT2C-Cerulean receptors and treated with DAMGO (10 μM) (black
circles), sufentanyl (1 μM) (red circles), morphine (10 μM) (open circles) or morphine (10 μM) plus 5-HT
(10 μM) (blue circles) for 15 minutes. Each point represents the mean ± SEM of at least three
independent assays.
doi:10.1371/journal.pone.0122604.g004
Evaluation of Receptor Endocytosis by Microscopy
PLOS ONE | DOI:10.1371/journal.pone.0122604 April 7, 2015 10 / 18
According to the mostly established and accepted classical theories in receptor pharmacolo-
gy, the receptor concept is conceived as a system where a particular input in chemical form (ag-
onist compound) results in a detectable output in form of biological response. That amount of
response or effect should be measurable by analytical means and the capacity of any given com-
pound to produce it is known as efficacy. Then, different drugs may have varying capacities to
initiate a response through a particular receptor and there is not an absolute scale for efficacy
but rather it is a dealt with in relative terms, i.e. the ratio of the efficacy of two different drugs
on a particular biological system [16]. To further validate our methodology to evaluate receptor
endocytosis as a functional pharmacological assay, MOP-YFP receptor endocytosis experi-
ments in real time were performed by using different concentrations of the agonist DAMGO.
Fig 5A displays the different kinetic curves obtained with different doses of DAMGO; thus, ei-
ther 10 nM, 30 nM or 100 nM produced undetectable responses in terms of endocytic vesicles
along 15 minutes of image acquisition. Per contra, higher amounts of DAMGO, i.e., 300 nM,
1 μM and 10μM, generated the formation of endocytic vesicles in a dose dependent manner
(Fig 5A). When the maximal response obtained with different DAMGO concentrations from
three independent experiments were plotted on a semi logarithmic graph, a sigmoidal dose-re-
sponse curve corresponding to the effect of DAMGO on MOP-YFP endocytosis was obtained
Table 1. Kinetic parameters obtained from endocytosis assays performed with cells heterologously expressing MOP-YFP receptors.
t1/2(min.) Emax (no. vesicles/cell) Slope n
DAMGO 5.02 ± 0.20 21.29 ± 1.49 0.59 ± 0.05 5
Sufentanyl 5.62 ± 0.31 23.44 ± 2.60 0.47 ± 0.04 5
Methadone 5.69 ± 0.36 26.16 ± 2.34 0.39 ± 0.05 3
Morphine n.d. n.d. n.d. 3
Oxycodone n.d. n.d. n.d. 3
Buprenorphine n.d. n.d. n.d. 3
Cells were treated with DAMGO (10 μM), sufentanyl (1 μM), methadone (10 μM), morphine (10 μM), oxycodone (10 μM) or buprenorphine (10 μM) for 15
minutes. Data indicate mean ± SEM of (n) independent experiments. t1/2: time to reach the 50% of the maximal response (minutes). Emax: maximal
response (number of vesicles per cell). n.d.: not detected.
doi:10.1371/journal.pone.0122604.t001
Table 2. Kinetic parameters obtained from endocytosis assays performed with cells heterologously co-expressing MOP-YFP and c-myc-
5-HT2C-Cerulean receptors.
t1/2 (min.) Emax (no. vesicles/cell) Slope n
DAMGO 4.82 ± 0.24 21.00 ± 2.41 0.53 ± 0.01 5
Sufentanyl 4.74 ± 0.47 19.69 ± 3.26 0.74 ± 0.12 4
Methadone 5.92 ± 0.61 29.28 ± 2.56 0.43 ± 0.08 3
Morphine n.d. n.d. n.d. 3
Morphine + 5-HT 7.38 ± 0.70 14.72 ± 0.27 0.46 ± 0.04 5
Morphine + DOI 8.47 ± 1.09 8.18 ± 1.31 0.47 ± 0.13 5
Morphine + WAY161503 8.86 ± 0.93 9.08 ± 1.88 0.31 ± 0.04 4
Oxycodone + 5-HT n.d. n.d. n.d. 3
Buprenorphine + 5-HT n.d. n.d. n.d. 3
Cells were treated with DAMGO (10 μM), sufentanyl (1 μM), methadone (10 μM), morphine (10 μM), morphine (10 μM) plus 5-HT (10 μM), morphine
(10 μM) plus DOI (10 μM), morphine (10 μM) plus WAY161503 (1 μM), oxycodone (10 μM) plus 5-HT (10 μM) or buprenorphine (10 μM) plus 5-HT
(10 μM). Data indicate mean ± SEM of (n) independent experiments. t1/2: time to reach the 50% of the maximal response (minutes). Emax: maximal
response (number of vesicles per cell). n.d.: not detected.
doi:10.1371/journal.pone.0122604.t002
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(Fig 5B) resulting in a potency (pEC50) of 6.21 ± 0.15. This value is comparable to the one pre-
viously obtained with the same agonist in [35S]GTPγS binding assays performed with mem-
branes from Flp-In HEK 293 cells permanently expressing MOP-YFP receptors (7.58 ± 0.09) [4].
In a similar manner, if the facilitation of MOP-YFP endocytosis by morphine observed with
serotonin is mediated by the activation of c-myc-5-HT2C-Cerulean receptors, a dose depending
response should be anticipated when assessing different concentrations of serotonin. Results
from three independent experiments demonstrating this assumption are shown in Fig 6; brief-
ly, lowest doses of serotonin (1nM and 10 nM) produced no facilitation of MOP-YFP
Fig 5. Effect of different doses of DAMGO on the time-course generation of endocytic vesicles containing MOP-YFP receptors. A. Data graph show
representative results from time-course MOP-YFP receptor endocytosis experiments performed with DAMGO at different concentrations (see symbol
legends).B. Dose-response curve obtained after non-linear analysis of data corresponding to the maximal effect in terms of number of vesicles per cells
generated by different concentrations of DAMGO. Each point represents the mean ± SEM of three independent experiments.
doi:10.1371/journal.pone.0122604.g005
Fig 6. Effect of different doses of serotonin (5-HT) on the facilitation of the endocytosis of MOP-YFP receptors by morphine. A. Data graph display
representative results from time-course MOP-YFP receptor endocytosis experiments conducted by co-treatment with morphine at 10 μM plus 5-HT at
different concentrations (see symbol legends).B. Dose-response curve (continuous line) obtained after non-linear analysis of the maximal effect (number of
vesicles per cell) generated by morphine (10 μM) plus different concentrations of 5-HT. Each point represents the mean ± SEM of three independent
experiments. Dotted line display the characteristic bell shaped profile observed when connecting these points in an increasing dose-dependent manner.
doi:10.1371/journal.pone.0122604.g006
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endocytosis by morphine whereas higher doses (10 nM, 100 nM, 1 μM and 10 μM) resulted in
the appearance of endocytic vesicles in a time dependent manner (Fig 6A). Unexpectedly, the
highest and fastest effect was observed with serotonin at 100 nM rather than with more concen-
trated doses such as 1 μM or 10 μM, leading to a bell shaped dose-response curve when these re-
sults were plotted in a semi logarithm graph (Fig 6B). Non-linear regression of these data points
fitted to a sigmoid dose-response function resulting in a potency (pEC50) of serotonin to that fa-
cilitation effect of 8.07 ± 0.52 (Fig 6B). This value is in accordance with the potency of serotonin
to mobilize intracellular calcium stores through 5-HT2C-GFP receptors transiently expressed in
HEK293 cells (1.80 ± 0.7 nM) [15]. Although the elucidation of the underlying molecular mech-
anisms responsible of this bell shaped profile is out of the scope of the present work, future inves-
tigations will be considered to explore the possible causes of such atypical response. Two main
hypothesis could be regarded as speculative explanations: one of them is the coupling of 5-HT2C
receptors to different signalling pathways depending on the serotonin concentration acting in
the system, and the other one is the presence of additional serotonin receptor subtypes endoge-
nously expressed in HEK 293 cells presenting an inhibitory effect on the facilitation of c-myc-
5-HT2C-Cerulean receptors at high serotonin concentrations.
The applicability of this method to a different GPCR was tested by using delta opioid recep-
tor (DOP) tagged to YFP at the carboxi terminus since earlier investigations conducted in HEK
293 cells heterologously expressing either MOP or DOP receptors already described their en-
docytosis as a consequence of binding to opioid agonists [17]. Consequently, DOP-YFP recep-
tors were transiently expressed in parental Flp-In HEK 293 cells to be submitted to agonist
treatment in real time fluorescence microscopy assays. Similarly as observed for MOP-YFP re-
ceptors permanently expressed in Flp-In HEK 293 cells, DOP-YFP receptors clearly internal-
ized upon treatment with the enkephalin analogue DTLET ([D-Thr2-Leu5]Enkephalin-Thr)
(S2 Video). Results obtained from three independent experiments are shown in Fig 7. Briefly,
Fig 7. Time course of the generation of endocytic vesicles containing either DOP-YFP or MOP-YFP
receptors transiently expressed in Flp-In T-REx HEK293 cells upon agonist treatment. Time-course
curves showing the generation of endocytic vesicles obtained from images of cells expressing DOP-YFP or
MOP-YFP receptors upon treatment with DTLET (10 μM) and DAMGO (10 μM) respectively.
doi:10.1371/journal.pone.0122604.g007
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treatment of cells with DTLET (10 μM) resulted in a time-dependent increase of the number of
endocytic vesicles following a sigmoid curve with the next kinetic parameters: t1/2 =
11.90 ± 0.61 minutes, Emax = 13.84 ± 0.30 vesicles/cell and Slope = 0.16 ± 0.03 (n = 3). These
data indicate that DOP-YFP receptor endocytosis process is appreciably slower than the one
observed for MOP-YFP receptor in DAMGO treatment assays (Table 1). To control this issue
in the same expression system, MOP-YFP receptors were transiently expressed in Flp-In HEK
293 cells to be treated with DAMGO at 10 μM for 30 minutes. Fig 7 displays the kinetic curve
obtained from three independent experiments that resulted in the following values confirming
the differences between MOP-YFP and DOP-YFP receptors: t1/2 = 7.54 ± 0.29 minutes,
Emax = 14.11 ± 0.28 vesicles/cell and Slope = 0.44 ± 0.11 (n = 3). Another difference between
MOP-YFP and DOP-YFP endocystosis processes, also discernible when both kinetic curves are
plotted in the same graph, is the slight constitutive endocytosis of DOP-YFP detectable in basal
conditions in absence of agonist stimulation (Fig 7).
Trafficking of GPCRs is regulated by a vast variety of cellular interacting proteins [1, 18].
Therefore, and similarly as described for other functional responses, for any given receptor
type different cellular hosts should have distinctive efficiencies of coupling to effectors that de-
termines, for instance, the characteristics of endocytosis processes. To further explore on this
circumstance by the analytical approach described herein, MOP-YFP receptors were transient-
ly expressed in HeLa cells and endocytosis experiments were conducted in real time by fluores-
cence microscopy. Fig 8 compiles results obtained from three independent assays using
DAMGO, sufentanyl and morphine as agonist drugs.
Comparatively as observed in Flp-In HEK 293 cells, morphine totally failed to induce any
endocytosis of MOP-YFP receptors. Conversely, either DAMGO as sufentanyl caused a signifi-
cant formation of internalizing vesicles in a time dependent manner (Fig 8) (S3 Video). Table 3
summarizes the kinetic parameters obtained from the analysis of DAMGO and sufentanyl
Fig 8. Time course of the generation of endocytic vesicles containing MOP-YFP receptors transiently
expressed in HeLa cells upon treatment with different agonists. Time-course curves showing the
generation of endocytic vesicles after treatment with DAMGO (10 μM), sufentanyl (1 μM) or morphine (10 μM)
in HeLa cells expressing MOP-YFP receptors.
doi:10.1371/journal.pone.0122604.g008
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curves; in both cases, the process was significantly slower than the equivalent one occurred in
FLP-In HEK 293 cells (t-test P<0.05, when comparing either t1/2 or Slope). Another significant
disparity between FLP-In HEK 293 and HeLa cell results was the maximal effect obtained for
both opioid agonists in terms of number of vesicles detected per cell (Tables 1 and 3). The rea-
son for this discrepancy may be due to the phenotypic differences between these cell lines since
HeLa cells, although thinner than HEK 293 (4 μM versus10 μM respectively), are notice-
ably larger than HEK 293 (compare bar scale and cell size between images from S2 Video and
S3 Video). Altogether, these results confirm what is accepted for other experimental models to
evaluate functionality in receptor pharmacology studies, that is, efficacy as a magnitude rather
than being an absolute value it should be considered in relative terms when comparing two dif-
ferent drugs on a particular biological system.
Other methodologies previously described to quantitative assess GPCRs endocytosis are
also based on mathematical algorithms to detect fluorescent aggregates in images obtained by
microscopy. This is the case of the ArrayScan technology initially developed as a high-content
screening system [19–20] to be used with cells heterologously expressing receptor-fluorescent
protein fusion conjugates such as parathyroid hormone receptor PTH-GFP or β2-GFP adreno-
ceptor, and lately validated with serotonin 5-HT2C-GFP [15], vasopressin V1a-GFP, proton
sensing TDAG8-GFP and free fatty acid GPR120-GFP receptors [21]. Although this technolo-
gy permits to conduct receptor functional studies comparable, at some extent, to other more
conventional pharmacology assays [15], its main technical limitation lies in the inability to de-
fine plasma membrane and, thereby, to eliminate this background signal. Besides this lack of
discrimination of the fluorescent signal originated at the plasma membrane, the major differ-
ence between ArrayScan algorithm and the new one described herein resides in the nature of
the fluorescent object to be detected and therefore quantified. Thus, the former method consid-
ers as quantifiable ‘spots’ the accumulation of endocytic vesicles in larger structures close to the
nuclear compartment also defined as perinuclear endocytic recycling (ERC) compartment
[19–22], whereas the novel approach described in here is capable to identify individual vesicles
from the commencement of the endocytosis process and at different cellular locations. This
higher versatility confers to our method the temporal and operational resolution necessary to
carry out functional experiments in real time. Previous investigations attempted to analyse the
timing of receptor endocytosis finding out the onset and duration of the process [23]; these
studies consisted in the examination in real time of the internalization of cAR1 receptors upon
external stimulation by cAMP in vivo in Dictyostelium discoideum by single-molecule micros-
copy. However, although this is a very sensitive imaging technology, it requires some methodo-
logical requirements that makes its implementation difficult to perform, i.e., previous
photobleaching of the sample or acquisition of stacks of 100 images with a time lag between
images of 5 ms.
The validation of the procedure described in this report with different GPCRs as well as di-
verse cellular phenotypes further supports the applicability of this method to varied
Table 3. Kinetic parameters obtained from endocytosis assays performed with HeLa cells transiently expressing MOP-YFP receptors.
t1/2 (min.) Emax (no. vesicles/cell) Slope n
DAMGO 9.60 ± 0.48 50.85 ± 3.89 0.19 ± 0.04 3
Sufentanyl 7.83 ± 0.45 62.25 ± 3.95 0.18 ± 0.04
Morphine n.d. n.d. n.d. 3
Cells were treated with DAMGO (10 μM), sufentanyl (1 μM) or morphine (10 μM) for 15 minutes. Data indicate mean ± SEM of (n) independent
experiments. t1/2: time to reach the 50% of the maximal response (minutes). Emax: maximal response (number of vesicles per cell). n.d.: not detected.
doi:10.1371/journal.pone.0122604.t003
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experimental situations. In fact, the only prerequisite for the use of this methodology is to have
a level of receptor expression in the heterologous system that permits the detection of endo-
somes by fluorescence microscopy.
In conclusion and based on already described algorithms to detect cellular punctuate objects
in single particle tracking studies, we have implemented an image analysis method to evaluate
receptor endocytosis as a pharmacological response by fluorescence living cell microscopy. The
functional and temporal resolution of this new approach is high enough to characterize the
pharmacological profile of those chemical compounds used to initiate this biological process.
In this sense, the contribution of experimental tools as the one described herein is essential to
determine the intrinsic activity of potential drug candidates when considering endocytosis as a
druggable target.
Supporting Information
S1 Fig. Characterization of endosomes from real microscopy images. A,B: 3D plots of a rep-
resentative endosome before (A) and after (B) smoothing the image with a Gaussian filter of
sigma = 1 pixel. X and Y axis units are pixels whereas Z axis corresponds to fluorescence inten-
sity (a.f.u.). C: Box-and-Whisker plots of sigma values (pixels) of local maxima corresponding
to endosomes (gray box) or to other non-endosome cellular structures, mainly plasma mem-
brane (white box).D: Box-and-Whisker plots of correlation values corresponding to the fitting
to a 2D-Gaussian function of sigma = 2.17 pixels obtained from endosomes (gray box) and
non-endosome structures (white box).
(TIFF)
S2 Fig. Flow-chart cartoon summarizing Q-Endosomes algorithm rationale.
(TIFF)
S3 Fig. Model to simulate endosome formation. A: Image from untreated cells obtained after
Z-stack maximum projection. B: Thresholding of image A to separate those areas containing
cells. C: Random distribution of simulated endosomes on these regions corresponding to cells.
D:Merging of images A and C.
(TIF)
S4 Fig. A: Accuracy of the Q-endosomes algorithm varying the radio of the region to be fit-
ted from 2 to 7 pixels. The figure shows the ratio found between the number of detected and
simulated endosomes, averaged across 10 independent simulations. Inset graph indicates the
relative error between simulated and detected values. B: surface graph showing the relative
error found between simulated and detected values from simulations performed by simulta-
neously modifying values corresponding to threshold above local background and correlation
coefficient of the 2D-Gaussian function.
(TIFF)




S1 Video. Real time images obtained from living cells by fluorescence microscopy. The fluo-
rescent signal corresponds to MOP-YFP receptors and the final image is the result of the Z-
stack maximal projection. Cells were treated for 15 minutes with the following agonists:
DAMGO (10 µM), morphine (10 µM), sufentanyl (1 µM) and morphine (10 µM) plus
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serotonin (10 µM). Images were acquired every 1 minute. Clock in the top left corner of each
panel indicates real time in minutes.
(MOV)
S2 Video. Real time images from Flp-In HEK 203 cells transiently expressing DOP-YFP re-
ceptors. Cells were treated with 10 µM of DTLET for 30 minutes. Images were acquired every
2 minutes. Clock in the top left corner indicates real elapsed time in minutes.
(MOV)
S3 Video. Real time images from HeLa cells transiently expressing MOP-YFP receptors.
Cells were treated with 10 µM of DAMGO for 15 minutes and images were acquired every 1
minute. Clock in the top left corner indicates real elapsed time in minutes.
(MOV)
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